Field crew now assessing White Rock’s Red Mountain project

|

Published 30-MAY-2018 11:39 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

White Rock Minerals Ltd (ASX:WRM) has released an update from its zinc VMS Red Mountain project in Alaska, stating that field crews have commenced on-ground assessment of recently identified regional exploration targets.

WRM identified a number of high priority VMS targets in the lead up to the 2018 field season, which are outside the known high grade zinc–silver–lead–gold VMS deposits at the Dry Creek and West Tundra prospects.

These high priority VMS targets are “conductors located within zones of anomalous surface geochemistry that are indicative of proximal VMS mineralisation”.

The targets were identified through an assessment undertaken by recognised global VMS expert, Dr Jim Franklin of existing surface geochemical data combined with a detailed interpretation of existing EM and magnetics surveys by Condor Consulting.

Franklin and Condor Consulting were able to use the known deposits at Dry Creek and West Tundra Flats to calibrate their assessment of the regional data, with the resulting assessment indicating that the Dry Creek West, ReRun, West Tundra, Rod, Smog and Glacier target areas are highly prospective for additional VMS deposits. Further, a number of high priority conductors were identified as having the potential of being caused by massive sulphide mineralisation.

According to the assessment, the highest priority conductors are located within the geochemical target areas, some of which are “coincident with strong base metal and precious metal anomalies from historic sampling”.

Field assessment commences

WRM’s field crews have now commenced their field assessment at the highest priority targets with the intention of undertaking mapping and surface sampling prior to selecting targets for drill testing throughout the 2018 campaign.

Field crews have already been able to assess a number of conductivity targets, as well as the associated proximal soil geochemical anomalies.

The next stage for WRM will be detailed mapping and sampling of prioritised prospects ahead of drill testing. The company anticipates a handheld XRF will be utilised to rapidly validate the location and tenor of historic surface zinc, lead, silver and copper anomalism prior to locating drill holes to test the new targets, without the need for samples to be submitted to the laboratory and subsequent long lead time to surface geochemistry results.

Of course, as with all minerals exploration, success is not guaranteed — consider your own personal circumstances before investing, and seek professional financial advice.

The Company’s Exploration Manager at Dry Creek West looking west along strike within the footwall alteration zone, with Red Mountain in the background.Field reconnaissance team at ReRun prospect.


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X